MedTrace Logo

The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration

NCT00227357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2010-06-07

No results posted yet for this study

Summary

The goal of this study is to develop and evaluate an innovative model of care to better serve patients who are both HIV-infected and opioid-dependent.

Conditions

  • HIV Infections
  • AIDS
  • Opiate Dependence
  • Post-Traumatic Stress Disorders

Interventions

DRUG

On-site - buprenorphine/naloxone (Suboxone)

Tablet, sub-lingual, 8/2 mg, 1-3 daily

DRUG

Off-site - methadone or no agonist

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • The New York Academy of Medicine

    collaborator OTHER

  • Ruth M. Rothstein CORE Center

    lead OTHER

Principal Investigators

  • Jeffrey D. Watts, M.D. · The CORE Center and John H. Stroger, Jr. Hospital of Cook County, Affiliates of the Cook County Bureau of Health Services

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00227357 on ClinicalTrials.gov